✦ LIBER ✦
6504 ORAL Safety and Efficacy of Epirubicin, Cisplatin, and Capecitabine (ECX) Plus Rilotumumab (R) as First-line Treatment for Unresectable Locally Advanced (LA) or Metastatic (M) Gastric or Esophagogastric Junction (EGJ) Adenocarcinoma
✍ Scribed by Iveson, T.; Donehower, R.C.; Davidenko, I.; Tjulandin, S.; Deptala, A.; Harrison, M.; Loh, E.; Jiang, Y.; Oliner, K.; Dubey, S.
- Book ID
- 122396943
- Publisher
- Elsevier Science
- Year
- 2011
- Tongue
- English
- Weight
- 44 KB
- Volume
- 47
- Category
- Article
- ISSN
- 0959-8049
No coin nor oath required. For personal study only.